• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿德福韦(PMEA)和替诺福韦酯与抗逆转录病毒化合物联合使用的抗HIV活性:体外分析

Anti-HIV activity of adefovir (PMEA) and PMPA in combination with antiretroviral compounds: in vitro analyses.

作者信息

Mulato A S, Cherrington J M

机构信息

Gilead Sciences, Foster City, CA 94404, USA.

出版信息

Antiviral Res. 1997 Nov;36(2):91-7. doi: 10.1016/s0166-3542(97)00043-0.

DOI:10.1016/s0166-3542(97)00043-0
PMID:9443665
Abstract

Adefovir (PMEA, 9-(2-phosphonomethoxyethyl)adenine), an acyclic nucleoside phosphonate analogue is active against retroviruses, hepadnaviruses and herpesviruses. Adefovir dipivoxil, an orally bioavailable prodrug of adefovir is currently in phase III clinical trials for the treatment of HIV and phase II clinical trials for the treatment of HBV infections. PMPA (9-(2-phosphonomethoxypropyl)adenine) is a related acyclic nucleoside phosphonate analogue that has demonstrated potent anti-SIV activity in rhesus macaques and recently has shown marked anti-HIV activity in a phase I clinical study. Since the standard of care for AIDS patients has become combination therapy, the effects of other antiretroviral compounds (d4T, ddC, AZT, ddI, 3TC, nelfinavir, ritonavir, indinavir, and saquinavir) on the anti-HIV activity of adefovir and PMPA were investigated in vitro. Adefovir and PMPA both demonstrated strong synergistic anti-HIV activity in combination with AZT. Adefovir demonstrated minor to moderate synergistic inhibition of HIV replication in combination with PMPA, d4T, ddC, nelfinavir, ritonavir, and saquinavir. PMPA demonstrated minor synergistic inhibition of HIV replication in combination with ddI and nelfinavir (and adefovir). All other combinations showed additive inhibition of HIV replication in vitro. Importantly, no antagonistic interactions were measured for any of the adefovir or PMPA combinations.

摘要

阿德福韦(PMEA,9 -(2 - 膦酰甲氧基乙基)腺嘌呤),一种无环核苷膦酸酯类似物,对逆转录病毒、嗜肝DNA病毒和疱疹病毒具有活性。阿德福韦酯,阿德福韦的一种口服生物利用度前药,目前正处于治疗HIV的III期临床试验和治疗HBV感染的II期临床试验阶段。PMPA(9 -(2 - 膦酰甲氧基丙基)腺嘌呤)是一种相关的无环核苷膦酸酯类似物,已在恒河猴中显示出有效的抗SIV活性,并且最近在一项I期临床研究中显示出显著的抗HIV活性。由于艾滋病患者的标准治疗已成为联合治疗,因此在体外研究了其他抗逆转录病毒化合物(d4T、ddC、AZT、ddI、3TC、奈非那韦、利托那韦、茚地那韦和沙奎那韦)对阿德福韦和PMPA抗HIV活性的影响。阿德福韦和PMPA与AZT联合使用时均表现出强大的协同抗HIV活性。阿德福韦与PMPA、d4T、ddC、奈非那韦、利托那韦和沙奎那韦联合使用时,对HIV复制表现出轻微至中度的协同抑制作用。PMPA与ddI和奈非那韦(以及阿德福韦)联合使用时,对HIV复制表现出轻微的协同抑制作用。所有其他组合在体外均表现出对HIV复制的相加抑制作用。重要的是,对于任何阿德福韦或PMPA组合,均未检测到拮抗相互作用。

相似文献

1
Anti-HIV activity of adefovir (PMEA) and PMPA in combination with antiretroviral compounds: in vitro analyses.阿德福韦(PMEA)和替诺福韦酯与抗逆转录病毒化合物联合使用的抗HIV活性:体外分析
Antiviral Res. 1997 Nov;36(2):91-7. doi: 10.1016/s0166-3542(97)00043-0.
2
Chemokines, nitric oxide and antiarthritic effects of 9-(2-phosphonomethoxyethyl)adenine (Adefovir).趋化因子、一氧化氮与9-(2-膦酰甲氧基乙基)腺嘌呤(阿德福韦)的抗关节炎作用
Eur J Pharmacol. 1999 Jul 2;376(1-2):91-100. doi: 10.1016/s0014-2999(99)00343-x.
3
In vitro selection and characterization of HIV-1 with reduced susceptibility to PMPA.对替诺福韦酯敏感性降低的HIV-1的体外筛选与特性分析
Antivir Ther. 1999;4(2):87-94. doi: 10.1177/135965359900400205.
4
Antiviral activities of 9-R-2-phosphonomethoxypropyl adenine (PMPA) and bis(isopropyloxymethylcarbonyl)PMPA against various drug-resistant human immunodeficiency virus strains.9-R-2-膦酰甲氧基丙基腺嘌呤(PMPA)和双(异丙氧基甲基羰基)PMPA对多种耐药性人类免疫缺陷病毒株的抗病毒活性。
Antimicrob Agents Chemother. 1998 Jun;42(6):1484-7. doi: 10.1128/AAC.42.6.1484.
5
Tenofovir, adefovir, and zidovudine susceptibilities of primary human immunodeficiency virus type 1 isolates with non-B subtypes or nucleoside resistance.具有非B亚型或核苷类耐药性的原发性1型人类免疫缺陷病毒分离株对替诺福韦、阿德福韦和齐多夫定的敏感性
AIDS Res Hum Retroviruses. 2001 Aug 10;17(12):1167-73. doi: 10.1089/088922201316912772.
6
Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPA.无环核苷膦酸酯9-R-(2-膦酰甲氧基丙基)腺嘌呤(PMPA)的一种潜在前药双(异丙氧基甲基羰基)PMPA的抗人免疫缺陷病毒活性和细胞代谢
Antimicrob Agents Chemother. 1998 Mar;42(3):612-7. doi: 10.1128/AAC.42.3.612.
7
Potent differentiation-inducing properties of the antiretroviral agent 9-(2-phosphonylmethoxyethyl) adenine (PMEA) in the rat choriocarcinoma (RCHO) tumor cell model.
Biochem Pharmacol. 1998 Oct 1;56(7):851-9. doi: 10.1016/s0006-2952(98)00058-6.
8
Prevention of murine AIDS development by (R)-9-(2-phosphonylmethoxypropyl)adenine.
J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Aug 1;18(4):316-22. doi: 10.1097/00042560-199808010-00002.
9
Pronounced in vitro and in vivo antiretroviral activity of 5-substituted 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy] pyrimidines.5-取代的2,4-二氨基-6-[2-(膦酰甲氧基)乙氧基]嘧啶具有显著的体外和体内抗逆转录病毒活性。
J Antimicrob Chemother. 2007 Jan;59(1):80-6. doi: 10.1093/jac/dkl454. Epub 2006 Nov 22.
10
In vitro selection and molecular characterization of human immunodeficiency virus type 1 with reduced sensitivity to 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA).对9-[2-(膦酰甲氧基)乙基]腺嘌呤(PMEA)敏感性降低的1型人类免疫缺陷病毒的体外筛选及分子特征分析
Antiviral Res. 1996 Oct;32(2):91-8. doi: 10.1016/0166-3542(95)00985-x.

引用本文的文献

1
Preparation and Characterization of 3D-Printed Dose-Flexible Printlets of Tenofovir Disoproxil Fumarate.制备并表征富马酸替诺福韦二吡呋酯 3D 打印剂量灵活的打印小片。
AAPS PharmSciTech. 2023 Aug 11;24(6):171. doi: 10.1208/s12249-023-02623-7.
2
Synthesis and Evaluation of Anti-HIV Activity of Mono- and Di-Substituted Phosphonamidate Conjugates of Tenofovir.合成与评价单取代和双取代磷酰胺酸酯类替诺福韦酯缀合物的抗 HIV 活性。
Molecules. 2022 Jul 12;27(14):4447. doi: 10.3390/molecules27144447.
3
Comparative Antiviral Activity of Remdesivir and Anti-HIV Nucleoside Analogs Against Human Coronavirus 229E (HCoV-229E).
比较瑞德西韦和抗 HIV 核苷类似物对人冠状病毒 229E(HCoV-229E)的抗病毒活性。
Molecules. 2020 May 17;25(10):2343. doi: 10.3390/molecules25102343.
4
M48U1 and Tenofovir combination synergistically inhibits HIV infection in activated PBMCs and human cervicovaginal histocultures.M48U1 与替诺福韦联合使用可协同抑制激活的 PBMC 和人宫颈组织培养物中的 HIV 感染。
Sci Rep. 2017 Feb 1;7:41018. doi: 10.1038/srep41018.
5
In Vitro Virology Profile of Tenofovir Alafenamide, a Novel Oral Prodrug of Tenofovir with Improved Antiviral Activity Compared to That of Tenofovir Disoproxil Fumarate.替诺福韦艾拉酚胺的体外病毒学特征,替诺福韦的一种新型口服前药,与富马酸替诺福韦二吡呋酯相比具有更高的抗病毒活性。
Antimicrob Agents Chemother. 2015 Oct;59(10):5909-16. doi: 10.1128/AAC.01152-15. Epub 2015 Jul 6.
6
The combined anti-HIV-1 activities of emtricitabine and tenofovir plus the integrase inhibitor elvitegravir or raltegravir show high levels of synergy in vitro.恩曲他滨和替诺福韦联合整合酶抑制剂埃替格韦或拉替拉韦的抗HIV-1活性在体外显示出高度协同作用。
Antimicrob Agents Chemother. 2014 Oct;58(10):6145-50. doi: 10.1128/AAC.03591-14. Epub 2014 Aug 4.
7
Noninvasive high-throughput single-cell analysis of HIV protease activity using ratiometric flow cytometry.利用比率流式细胞术对 HIV 蛋白酶活性进行非侵入性高通量单细胞分析。
Sensors (Basel). 2013 Nov 28;13(12):16330-46. doi: 10.3390/s131216330.
8
From in vitro EC₅₀ to in vivo dose-response for antiretrovirals using an HIV disease model. Part II: application to drug development.从抗逆转录病毒的体外 EC₅₀ 到 HIV 疾病模型中的体内剂量反应。第二部分:在药物开发中的应用。
J Pharmacokinet Pharmacodyn. 2012 Aug;39(4):369-81. doi: 10.1007/s10928-012-9257-1. Epub 2012 Jul 8.
9
Development of dual-acting pyrimidinediones as novel and highly potent topical anti-HIV microbicides.开发新型、高效双重作用嘧啶二酮类化合物作为新型局部抗 HIV 微生态制剂。
Antimicrob Agents Chemother. 2011 Nov;55(11):5243-54. doi: 10.1128/AAC.05237-11. Epub 2011 Sep 6.
10
Intracellular nucleotide levels during coadministration of tenofovir disoproxil fumarate and didanosine in HIV-1-infected patients.在感染 HIV-1 的患者中同时给予替诺福韦酯和地达诺新时细胞内核苷酸水平。
Antimicrob Agents Chemother. 2011 Apr;55(4):1549-55. doi: 10.1128/AAC.00910-10. Epub 2011 Jan 31.